VIPStockReports.com gives you a free stock report on any company right on our site. You can get up to date stock information right from VIPStockReports.com on companies that you want to follow, including BioCyst Pharmaceuticals, Inc. (NasdaqGS:BCRX).
July 23 was a busy day for BioCyst which had a range of $3.29-$4.72 opening the 23rd at $3.61. The company’s volume on the 23rd was 12,198,759 with a 3 month volume average of 1,381,720. Their 52 week range is $1.08 and $4.95 with a market cap of 232.32. For more information on this company, you can go to vipstockreports.com in the window below to get a free stock report right now.
After the company reported the Phase I results for the oral kallefrien inhibitor, JMP Securities increased its target on BioCryst. The firm sees it as solid and positive as it keeps an Outperform rating on the stock and raised share prices from $3 to $5.
About VIPStockReports
VIPStockReports.com screens the markets looking for hot emerging Micro-cap and small cap stocks that look to run high. Once we find the next hot penny stock with monster upside potential we immediately email it to you in our detailed VIP Report so you can stay ahead of the bell.
